It is also present in many tumors, including breast, colorectal, and renal cancer tissues 9, 20, 21, and upregulation of CDH23 expression corresponds to a decrease of overall survival in patients with acute myeloid leukemia 22. This evidence concerns the gene CDH23 and renal carcinoma.